Accuracy of SD Malaria Ag P.f/Pan® as a rapid diagnostic test in French Amazonia.
Accuracy
Malaria
PfHRP2 gene deletion
Rapid diagnosis tests
Journal
Malaria journal
ISSN: 1475-2875
Titre abrégé: Malar J
Pays: England
ID NLM: 101139802
Informations de publication
Date de publication:
17 Sep 2021
17 Sep 2021
Historique:
received:
24
04
2021
accepted:
02
09
2021
entrez:
18
9
2021
pubmed:
19
9
2021
medline:
17
11
2021
Statut:
epublish
Résumé
French Guiana (FG) is a French overseas territory where malaria is endemic. The current incidence rate is 0.74‰ inhabitants, and Plasmodium vivax is widely predominating even though Plasmodium falciparum is still present due to imported cases mainly from Africa. In FG, rapid diagnostic test (SD Malaria Ag P.f/Pan®) is based on the detection of pan-pLDH, PfHRP2, and PfHRP3 antigens, while in South America, the share of deletion of PfHRP2 gene is significantly increasing. Accordingly, the study questions the reliability of RDTs in the Amazonian context. The study is retrospective. It is conducted over 4 years and analysed 12,880 rapid diagnostic tests (RDTs) compared to concomitant Blood Film Tests (BFTs) sampled for malaria diagnosis. The global assessment of the accuracy of SD Malaria Ag P.f/Pan® in the diagnostic of malaria shows both Positive and Negative Predictive Values (PPV and NPV) higher than 95%, except for PPV in the diagnosis of malaria to P. falciparum (88%). Overall, the concordance rate between RDT and BFT (positive/positive; negative/negative) was 99.5%. The PPV of the RDT in the follow-up of patients diagnosed with P. falciparum was the lowest during the first 28 days. The PPV of the RDT in the follow-up of patients diagnosed with P. vivax was the lowest during the first 21 days. The global sensitivity of SD Malaria Ag P.f/Pan® test was, on average, 96% (88.2-100) for P. falciparum and 93% (90.6-94.2) for P. vivax. The global specificity was 99.8% (99.5-100) for all included species. SD Malaria Ag P.f/Pan® is a reliable rapid test used for the first-line diagnosis in remote healthcare centres. The test results should be interpreted in the light of patient's recent medical history and the date of arrival to FG.
Sections du résumé
BACKGROUND
BACKGROUND
French Guiana (FG) is a French overseas territory where malaria is endemic. The current incidence rate is 0.74‰ inhabitants, and Plasmodium vivax is widely predominating even though Plasmodium falciparum is still present due to imported cases mainly from Africa. In FG, rapid diagnostic test (SD Malaria Ag P.f/Pan®) is based on the detection of pan-pLDH, PfHRP2, and PfHRP3 antigens, while in South America, the share of deletion of PfHRP2 gene is significantly increasing. Accordingly, the study questions the reliability of RDTs in the Amazonian context.
METHODS
METHODS
The study is retrospective. It is conducted over 4 years and analysed 12,880 rapid diagnostic tests (RDTs) compared to concomitant Blood Film Tests (BFTs) sampled for malaria diagnosis.
RESULTS
RESULTS
The global assessment of the accuracy of SD Malaria Ag P.f/Pan® in the diagnostic of malaria shows both Positive and Negative Predictive Values (PPV and NPV) higher than 95%, except for PPV in the diagnosis of malaria to P. falciparum (88%). Overall, the concordance rate between RDT and BFT (positive/positive; negative/negative) was 99.5%. The PPV of the RDT in the follow-up of patients diagnosed with P. falciparum was the lowest during the first 28 days. The PPV of the RDT in the follow-up of patients diagnosed with P. vivax was the lowest during the first 21 days. The global sensitivity of SD Malaria Ag P.f/Pan® test was, on average, 96% (88.2-100) for P. falciparum and 93% (90.6-94.2) for P. vivax. The global specificity was 99.8% (99.5-100) for all included species.
CONCLUSION
CONCLUSIONS
SD Malaria Ag P.f/Pan® is a reliable rapid test used for the first-line diagnosis in remote healthcare centres. The test results should be interpreted in the light of patient's recent medical history and the date of arrival to FG.
Identifiants
pubmed: 34535137
doi: 10.1186/s12936-021-03902-z
pii: 10.1186/s12936-021-03902-z
pmc: PMC8447521
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
369Informations de copyright
© 2021. The Author(s).
Références
Med Trop (Mars). 2009 Feb;69(1):19-25
pubmed: 19499726
Med Mal Infect. 2011 Jun;41(6):301-6
pubmed: 21498013
Malar J. 2020 Jan 29;19(1):50
pubmed: 31996210
Malar J. 2018 Jun 8;17(1):228
pubmed: 29884184
PLoS One. 2013 Sep 23;8(9):e74269
pubmed: 24086328
Mem Inst Oswaldo Cruz. 2014 Aug;109(5):525-33
pubmed: 25184998
Emerg Infect Dis. 2016 Feb;22(2):344-6
pubmed: 26811971
PLoS One. 2018 Jul 11;13(7):e0200492
pubmed: 29995953
Biotech Histochem. 2011 Feb;86(1):7-35
pubmed: 21235291
Rev Panam Salud Publica. 2021 Apr 28;45:e46
pubmed: 33936184
Ann Trop Med Parasitol. 2005 Sep;99(6):553-62
pubmed: 16156968
PLoS One. 2015 May 15;10(5):e0126805
pubmed: 25978499
J Clin Microbiol. 2004 Sep;42(9):4237-41
pubmed: 15365017
Malar J. 2016 Jun 09;15:315
pubmed: 27277831
Malar J. 2012 Apr 24;11:122
pubmed: 22531245
Malar J. 2009 Sep 07;8:211
pubmed: 19735557
BMC Infect Dis. 2020 May 26;20(1):373
pubmed: 32456698
Clin Microbiol Infect. 2019 May;25(5):580-585
pubmed: 30267926
J Clin Pathol. 1996 Jul;49(7):533-8
pubmed: 8813948
Cochrane Database Syst Rev. 2014 Dec 18;(12):CD011431
pubmed: 25519857
Malar J. 2012 Mar 29;11:95
pubmed: 22458802
Am J Trop Med Hyg. 2020 Jan;102(1):130-141
pubmed: 31769403
PLoS One. 2017 Mar 16;12(3):e0171150
pubmed: 28301474
J Clin Microbiol. 2014 Oct;52(10):3784-7
pubmed: 25056333
Malar J. 2021 Jun 22;20(1):276
pubmed: 34158065
Am J Trop Med Hyg. 2018 Jun;98(6):1683-1691
pubmed: 29557337
Sci Rep. 2017 May 18;7(1):2080
pubmed: 28522856
J Med Microbiol. 2013 Oct;62(Pt 10):1491-1505
pubmed: 24048274